What percentage of the prick testing concentration is used for intradermal allergy skin testing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intradermal Allergy Skin Testing Concentration

For intradermal allergy skin testing, use 1/100 (1%) to 1/1000 (0.1%) of the prick testing concentration, depending on the specific allergen and clinical context. 1, 2

Standard Dilution Protocol

The typical approach follows a sequential dilution strategy:

  • Start with prick/puncture testing at full strength (undiluted or standard concentration) 1
  • If prick testing is negative, proceed to intradermal testing at diluted concentrations 1, 3
  • Common intradermal dilutions range from 1:10 to 1:1000 of the prick test concentration 2, 4

Specific Examples from Guidelines

Drug Allergy Testing

  • Corticosteroids: Use 10% concentration for skin prick tests, then dilutions of 1:1000,1:100, and 1:10 for sequential intradermal testing 2
  • Penicillin: Full-strength reagents (Pre-Pen at 6 × 10⁻⁵ mol/L and penicillin G at 10,000 units/mL) are applied by prick technique first; if negative, proceed to intradermal testing at the same concentrations 1
  • Omalizumab: A nonirritating concentration for intradermal testing is 1:100,000 volume-to-volume dilution (1.25 mcg/mL) 1

General Allergen Testing

  • Intradermal injections use 0.01-0.02 mL (or up to 0.04-0.05 mL in some protocols) to create a 3-5 mm baseline wheal 1, 5, 4
  • Sequential dilutions (10⁻⁴, 10⁻³, 10⁻², 10⁻¹) may be used for certain drugs when performing intradermal tests 4

Critical Safety Considerations

Intradermal testing is more sensitive but less specific than prick testing, with higher risk of false positives and systemic reactions 1, 5:

  • Systemic reactions occur in 3.2% of intradermal tests versus 0.4% for prick tests 6
  • Always perform prick testing first before proceeding to intradermal testing to minimize risk 1
  • Use appropriate positive (histamine) and negative (saline) controls to validate results 1, 3

Reading and Interpretation

  • Read results at 15-20 minutes for immediate reactions 1, 3
  • A positive test is defined as a wheal ≥3 mm greater than negative control with a flare ≥5 mm 1, 7
  • Also read at delayed timepoints (D1, D2, D4, and 1 week) for certain drug reactions 4

Important Caveats

Do not perform intradermal testing without preceding negative prick tests, as this significantly increases the risk of severe systemic reactions, particularly in asthmatic patients 1. The one exception is when prick testing cannot be performed due to skin conditions like severe eczema or dermatographism 1, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Skin testing for immediate hypersensitivity to corticosteroids: a case series and literature review.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2015

Guideline

Diagnostic Approach to Allergies using Skin Prick Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Chapter 2: Skin testing in allergy.

Allergy and asthma proceedings, 2012

Research

Reactions to prick and intradermal skin tests.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2009

Guideline

Piperacillin-Tazobactam Allergy Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.